|
|
| (11) | Number of the document | C 1740177 |
| (68) | Number of the document | 1740177 |
| (21) | Application number for Supplementary Protection Certificate | PA 2014 038 |
| (22) | Date of filing the application | 2014-10-13 |
| (41) | Date of publication of the application | 2014-11-25 |
| Date of publication of SPC | 2016-06-27 | |
| (24) | Date of coming into effect of SPC | 2025-04-28 |
| (71) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (73) |
Glaxo Group Limited ,
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/14/922, 2014-04-28 |
| (94) | 2029-04-30 |
| (95) | Umeklidino bromidas |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 2 | 347.00 EUR |
| 2027-04-28 |
| SPC granted |